From: Olfactory dysfunction as a screening tool for mild and moderate cases of COVID-19: a single-center prevalence study of 646 patients in flu clinic
Co-morbidity
N (%)
No
483 (74.8)
Hypertension
89 (13.8)
Diabetes
40 (6.2)
Thyroid
22 (3.4)
Coronary artery disease
9 (1.4)
Tuberculosis
7 (1.1)
Asthma
Chronic kidney disease
4 (0.6)
Autoimmune
5 (0.8)
COPD
Carcinoma
3 (0.5)